Clinical trial
Assessment of CCM in HF With Higher Ejection Fraction
NCT05064709 · Impulse Dynamics, Industry · Recruiting
Key facts
| NCT number | NCT05064709 |
|---|---|
| Title | Assessment of CCM in HF With Higher Ejection Fraction |
| Official title | Assessment of Implantable CCM in the Heart Failure Group With Higher Ejection Fraction |
| Acronym | AIM HIGHer |
| Lead sponsor | Impulse Dynamics, Industry |
| Status | Recruiting |
| Study type | Interventional |
| Conditions | Heart Failure, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range Ejection Fraction, Heart Failure With Moderately Reduced Ejection Fraction, Diastolic Heart Failure |
| Intervention type | Device |
| Interventions | Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System, OPTIMIZER™ Smart Mini System |
| Enrollment | 1,500 |
| Start date | Feb 3, 2022 |
| Primary completion | Feb 1, 2029 |
| Completion | Feb 1, 2029 |
| First posted | Oct 1, 2021 |
| Last update posted | Jan 15, 2026 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- 10–99 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: